Big Pharma Is Losing a Fortune Trying to Cure Alzheimer’s – Bloomberg
Alzheimer’s disease is rewriting the rules of drug discovery, with a handful of companies abandoning caution to keep pursuing an elusive hypothesis because the potential payoff is so great.